Skip to main
RNTX
RNTX logo

RNTX Earnings Dates & Reports

RNTX Most Recent Earnings

Report DateNov 14, 2025
Period EndingQ3 2025
Est. EPS-$0.24
Actual EPS-$0.21
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RNTX Earnings per Share (EPS) History

Signup for full access
Browse free

RNTX Latest Earnings

The value each RNTX share was expected to gain vs. the value each share gained.

RNTX reported its most recent earnings on Nov 14, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.21. This exceeded analysts' expectations of -$0.24 by 12.50%, marking a Beat.

For comparison, Rein Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 04/06/2026, with analysts projecting an EPS of -$0.22.

RNTX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Mar 20, 2026
-$0.22Next earnings call Apr. 6, 2026
Q3 2025Nov 14, 2025
-$0.24-$0.21-12.50%
DeckReportListen
Q2 2025Aug 14, 2025
-$0.22-$0.28+27.27%
DeckReportListen

RNTX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Rein Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 14, 2025
Aug 14, 2025

RNTX Earnings FAQs

RNTX last reported earnings on Nov 14, 2025 for Q3 2025, posting an EPS of -$0.21, which Beat the estimate of -$0.24 by 12.50%.

For Q3 2025, RNTX reported an EPS of -$0.21, exceeding analysts' estimate of -$0.24 by 12.50%.

For Q3 2025, RNTX Beat expectations with an actual EPS of -$0.21 vs. an estimated EPS of -$0.24.

Following the last earnings report on Nov 14, 2025, RNTX's stock price moved — from — to —.

The next RNTX earnings call is scheduled for Apr. 6, 2026, where executives will discuss financial results and outlook.

Rein Therapeutics Inc (RNTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.